DINGDANG HEALTH Repurchases 164,500 Shares, Reducing Free Float by 0.013% on 25 September 2026

Bulletin Express09-25

DINGDANG HEALTH TECHNOLOGY GROUP LTD. conducted an on-market share buyback on 25 September 2026, acquiring 164,500 ordinary shares at prices ranging between HKD 0.78 and HKD 0.80 per share. The volume-weighted average purchase price was approximately HKD 0.79, bringing the total cash outlay to HKD 0.13 million.

Following the transaction, the company’s issued share capital (excluding treasury shares) fell from 1.23511 billion to 1.23495 billion shares, representing a 0.013% reduction. Concurrently, treasury share holdings increased from 5.20 million to 5.36 million shares, while the overall issued share count remained unchanged at 1.24 billion.

The buyback forms part of the repurchase mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, DINGDANG HEALTH has repurchased 8.22 million shares under this mandate, equal to 0.66% of the company’s issued share base at the time the authority was granted.

In accordance with Hong Kong Stock Exchange Main Board Rule 10.06(3)(a), a 30-day moratorium on new share issues and the sale or transfer of treasury shares is now in effect until 25 October 2026. The company affirmed that the repurchase complied with all applicable listing rules and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100659408?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-25 18:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100659408","market":"us","top_or_hot":-1,"title":"DINGDANG HEALTH Repurchases 164,500 Shares, Reducing Free Float by 0.013% on 25 September 2026","media":"Bulletin Express","content":"<p>DINGDANG HEALTH TECHNOLOGY GROUP LTD. conducted an on-market share buyback on 25 September 2026, acquiring 164,500 ordinary shares at prices ranging between HKD 0.78 and HKD 0.80 per share. The volume-weighted average purchase price was approximately HKD 0.79, bringing the total cash outlay to HKD 0.13 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) fell from 1.23511 billion to 1.23495 billion shares, representing a 0.013% reduction. Concurrently, treasury share holdings increased from 5.20 million to 5.36 million shares, while the overall issued share count remained unchanged at 1.24 billion.</p>\n<p>The buyback forms part of the repurchase mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, DINGDANG HEALTH has repurchased 8.22 million shares under this mandate, equal to 0.66% of the company’s issued share base at the time the authority was granted.</p>\n<p>In accordance with Hong Kong Stock Exchange Main Board Rule 10.06(3)(a), a 30-day moratorium on new share issues and the sale or transfer of treasury shares is now in effect until 25 October 2026. The company affirmed that the repurchase complied with all applicable listing rules and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DINGDANG HEALTH Repurchases 164,500 Shares, Reducing Free Float by 0.013% on 25 September 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDINGDANG HEALTH Repurchases 164,500 Shares, Reducing Free Float by 0.013% on 25 September 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-25 18:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DINGDANG HEALTH TECHNOLOGY GROUP LTD. conducted an on-market share buyback on 25 September 2026, acquiring 164,500 ordinary shares at prices ranging between HKD 0.78 and HKD 0.80 per share. The volume-weighted average purchase price was approximately HKD 0.79, bringing the total cash outlay to HKD 0.13 million.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) fell from 1.23511 billion to 1.23495 billion shares, representing a 0.013% reduction. Concurrently, treasury share holdings increased from 5.20 million to 5.36 million shares, while the overall issued share count remained unchanged at 1.24 billion.</p>\n<p>The buyback forms part of the repurchase mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, DINGDANG HEALTH has repurchased 8.22 million shares under this mandate, equal to 0.66% of the company’s issued share base at the time the authority was granted.</p>\n<p>In accordance with Hong Kong Stock Exchange Main Board Rule 10.06(3)(a), a 30-day moratorium on new share issues and the sale or transfer of treasury shares is now in effect until 25 October 2026. The company affirmed that the repurchase complied with all applicable listing rules and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1100659408","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100659408","pubTimestamp":1790332912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"DINGDANG HEALTH TECHNOLOGY GROUP LTD. conducted an on-market share buyback on 25 September 2026, acquiring 164,500 ordinary shares at prices ranging between HKD 0.78 and HKD 0.80 per share. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康于 2026 年 9 月 25 日回购 164,500 股股份，将自由流通量减少 0.013%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"DINGDANG HEALTH TECHNOLOGY GROUP LTD. conducted an on-market share buyback on 25 September 2026, acquiring 164,500 ordinary shares at prices ranging between HKD 0.78 and HKD 0.80 per share. The volume-weighted average purchase price was approximately HKD 0.79, bringing the total cash outlay to HKD 0.13 million.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) fell from 1.23511 billion to 1.23495 billion shares, representing a 0.013% reduction. Concurrently, treasury share holdings increased from 5.20 million to 5.36 million shares, while the overall issued share count remained unchanged at 1.24 billion.\nThe buyback forms part of the repurchase mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. To date, DINGDANG HEALTH has repurchased 8.22 million shares under this mandate, equal to 0.66% of the company’s issued share base at the time the authority was granted.\nIn accordance with Hong Kong Stock Exchange Main Board Rule 10.06(3)(a), a 30-day moratorium on new share issues and the sale or transfer of treasury shares is now in effect until 25 October 2026. The company affirmed that the repurchase complied with all applicable listing rules and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100659408","isCrawlerRequest":true}